| Literature DB >> 29436255 |
Yang Li1, Abdul Qadir Nawabi1, Yi Feng1, Genshan Ma1, Jiayi Tong1, Chengxing Shen2, Naifeng Liu1.
Abstract
Objective The clinical implication of coronary tortuosity is unclear. The present study was conducted to determine the relationships between coronary tortuosity and the high-sensitivity C-reactive protein (hs-CRP) concentration and between coronary tortuosity and cerebrovascular accident in hypertensive patients without coronary artery disease. Methods In total, 236 patients with normal coronary angiography findings were categorized into 3 different groups: control participants (n = 58), who had neither hypertension nor coronary tortuosity; patients with hypertension but no coronary tortuosity (H-NCT group, n = 93); and patients with both hypertension and coronary tortuosity (H-CT group, n = 85). The hs-CRP concentration was measured in every patient, and 168 hypertensive patients were followed up for at least 2 years to check for the development of cerebrovascular accident. Results The hs-CRP concentration was significantly higher in the H-CT group than in the control and H-NCT groups (4.33 ± 3.15 vs. 1.52 ± 1.31 and 2.31 ± 2.09 mg/L, respectively). The incidence of lacunar infarction was higher in the H-CT than H-NCT group during the follow-up. Conclusions Hypertensive patients with coronary tortuosity have a higher serum hs-CRP level concentration and have a higher incidence of lacunar infarction than hypertensive patients without coronary tortuosity.Entities:
Keywords: Coronary tortuosity; cerebrovascular accident; coronary artery disease; high-sensitivity C-reactive protein; hypertension; lacunar infarction
Mesh:
Substances:
Year: 2018 PMID: 29436255 PMCID: PMC6091816 DOI: 10.1177/0300060517748527
Source DB: PubMed Journal: J Int Med Res ISSN: 0300-0605 Impact factor: 1.671
Figure 1.Diagnosis of coronary artery tortuosity
Patients’ baseline clinical characteristics
| Variables | Control (n = 58) | H-NCT (n = 93) | H-CT (n = 85) |
|---|---|---|---|
| Men | 26 (44.8) | 48 (51.6) | 42 (49.4) |
| Age, years | 58 ± 7.9 | 62 ± 9.1 | 63 ± 8.6 |
| Systolic blood pressure, mmHg | 126 ± 10.1 | 142 ± 11.8 | 152 ± 13.0
|
| Diastolic blood pressure, mmHg | 76 ± 10.2 | 81 ± 10.9 | 83 ± 12.8 |
| Smoking | 8 (13.7) | 11 (11.8) | 12 (14.1) |
| Aspirin treatment | 6 (10.3) | 15 (16.1) | 19 (22.3) |
| LDL-cholesterol, mg/dL | 127 ± 6.6 | 128 ± 6.7 | 130 ± 7.5 |
| Hypertension duration, years | 0.0 ± 0.0 | 7.6 ± 2.7 | 9.9 ± 3.9 |
| White blood corpuscles, 109/L | 5.2 ± 1.4 | 6.3 ± 2.8 | 6.1 ± 2.6 |
| hs-CRP, mg/L | 1.52 ± 1.31 | 2.31 ± 2.09 | 4.33 ± 3.15* |
| Structural heart disease | 1 (1.7) | 1 (1.0) | 1 (1.1) |
| Heart failure | 1 (1.7) | 2 (2.1) | 2 (2.3) |
| Atrial fibrillation | 1 (1.7) | 1 (1.0) | 2 (2.3) |
Data are presented as n (%) or mean ± standard deviation.
H-NCT, hypertension but no coronary tortuosity; H-CT, hypertension and coronary tortuosity; LDL-cholesterol, low-density lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein
△p < 0.05 compared with H-NCT group. *p < 0.05 compared with control group and H-NCT group.
Cardiovascular events during follow-up
| Events | H-NCT | H-CT | p value |
|---|---|---|---|
| Stroke | 2 (2.2) | 6 (7.1) | 0.114 |
| Ischemic stroke | 2 (2.2) | 6 (7.1) | 0.114 |
| Lacunar infarction | 1 (1.1) | 6 (7.1) | 0.04 |
| Hemorrhagic stroke | 0 (0.0) | 0 (0.0) |
Data are presented as n (%). H-NCT, hypertension but no coronary tortuosity; H-CT, hypertension and coronary tortuosity.